目的探讨耐多药肺结核治疗失败的原因。
Objective To probe the reasons for ineffective treatment of drug-fast pulmonary tuberculosis.
结果表明肺切除术是治疗耐多药肺结核的重要方法。
这种肺结核被称为“耐多药肺结核”或MDR - TB。
This kind of TB is called multi-drug resistant tuberculosis or MDR-TB.
方法对11例耐多药肺结核患者治疗失败原因进行回顾性分析。
Methods Analysis of reasons for ineffective treatment of 11 cases of drug-fast pulmonary tuberculosis.
结论：左氧氟沙星治疗耐多药肺结核效果显著，值得推广应用。
Conclusion: Levofloxacin used in the treatment of the multi-drug resistant pulmonary tuberculosis is effective, and it is worthy of popularization and application.
目的观察纤维支气管镜介入治疗耐多药肺结核并支气管结核的疗效。
Objective To observe the curative effect of fiber bronchoscope involved in treatment of drug-fast pulmonary tuberculosis and bronchial tube tuberculosis.
目的：探讨人工气腹疗法对耐多药肺结核（MDRPTB）的治疗价值。
Objective:To appraise the therapeutic effect of artificial pneumoperitoneum on multi drug resistant pulmonary tuberculosis(MDR PTB).
世界卫生组织称“耐多药肺结核”的治疗费用比其他肺结核病贵一百多倍。
The World Health Organization says MDR-TB is one hundred times more costly to treat than the other form of the disease.
结论支气管动脉灌注，纤维支气管镜导管介入及化疗，耐多药肺结核疗效显著。
Conclusion the efficacy of bronchi artery injection bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis is obvious.
方法选择160例耐多药肺结核病人根据耐药情况进行统计学研究与回顾性分析。
Methods The curative effect of 160 multi-drug resistant pulmonary tuberculosis patients had been counted and analyze.
结论复方甘草酸苷用于耐多药肺结核肝功能损害患者保肝疗效可靠，不良反应少。
CONCLUSION: Compound glycyrrhizin has a reliable hepatoprotective efficacy and few adverse drug reactions in treating MDR-TB patients complicating with lesion of liver function.
纤维支气管镜介入治疗耐多药肺结核并支气管结核是一种安全的方法且临床效果好。
The interventional therapy of fiber bronchoscope involved in treatment of drug-fast pulmonary tuberculosis and the bronchial tube tuberculosis is safe and effective.
结论对耐多药肺结核采用含丁胺卡那、左氧氟沙星的方案治疗MDR-TB效果肯定。
Conclusion The treatment scheme of combine levofloxacin and amikacine was appropriate to apply on MDR-TB.
目的评价卷曲霉素、左氧氟沙星及对氨基水杨酸钠联合化疗方案在耐多药肺结核治疗中的效果。
Objective To evaluate the clinical efficacy of a combination therapy with capreomycin , levofloxacin and sodium aminosalicylate in the treatment of multi-drug resistant pulmonary tuberculosis.
目的了解人类免疫缺陷病毒(HIV)感染合并耐多药肺结核(MDR - TB)的成因及治疗效果。
ObjectiveTo explore the cause and treatment of multi-drug resistant pulmonary tuberculosis (MDR-TB) in patients with human immunodeficiency virus (HIV) infection.
方法：采用含卷曲霉素、结核清、氧氟沙星、复合利福平及吡嗪酰胺等抗结核药物方案对耐多药肺结核患者进行治疗。
Methods: The tuberculosis of multi-drug resistance were treated with capreomycin, pasinizide, ofloxacin, rifampin compound and pyrazinamide for one year.
不幸的是，那些感染了多药抗药性肺结核病的病人不得不服用效力较弱，但毒性更强，价格更高的药物。
Unfortunately, those infected with MDR have to be treated with less effective, more poisonous and more costly drugs.
在20世纪40年代末，一名老人被诊断出患有肺结核，这在当时是一个无药可救的传染病。
In the late 1940s, an old man was diagnosed with tuberculosis, an incurable infectious disease at that time.
特别危险的结核病是多抗药性结核病(multidrug - resistantTB)。这是抗拒至少两种最有效的抗肺结核药——异烟肼和利福平的结核病。
A particularly dangerous form of TB is multidrug-resistant TB (MDR-TB), which is TB that resists at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
一些人患上了严重的抗药性肺结核，无药可医。”Holloway说道。
There are some people with extreme drug-resistant TB and there are no drugs to treat them, " Holloway said.
在后来一次到南非的时候，我去了一家住有很多抗药性肺结核患者和耐多药结核病患者的医院，这是一种治愈率不到50%的顽疾。
On a later trip to South Africa, I paid a visit to a hospital for patients with MDR-TB, multi-drug resistant tuberculosis, a disease with a cure rate of under 50%.
结论对复治肺结核患者，特别是耐单药的肺结核患者采用个体化化疗方案可获得较好的疗效。
Conclusion for retreatment pulmonary tuberculosis patients, especially for those in single-drug resistant patients, individualized treating program has better therapeutic effect.
他们在对别的东西进行研究时，偶然发现了一种治疗肺结核的药。
They stumbled across a cure for tuberculosis while they were doing research on something else.
目的：研究经皮肺穿刺给药治疗耐多药空洞型肺结核的临床疗效。
Objective:to explore the clinical effects of perfusing chemotherapy by percutaneous lung puncture in the treatment of multi-drug resistent cavitary pulmonary tuberculosis(MDR-TB).
目的评价二线抗痨药降阶梯治疗对复治重症肺结核的疗效。
Objective To observe and evaluate the therapeutic efficacy in de-escalation treatment of retreated serious pulmonary tuberculosis with second-line anti-TB drugs.
食品和药物管理局四十年来首次批准肺结核特效药投入生产。
The first new medicine in 4 decades aimed to tuberculosis has been approved by the Food and Drug Administration.
结论：与单纯采用抗结核药进行治疗相比，乌体林斯联合抗结核药治疗肺结核球效果好，不良反应少。
Conclusion: Only using the anti-TB drug treatment compared with Utilin's combined with anti-TB drugs treatment of pulmonary tuberculosis, the latter is good effect, and less adverse reaction.
结论：与单纯采用抗结核药进行治疗相比，乌体林斯联合抗结核药治疗肺结核球效果好，不良反应少。
Conclusion: Only using the anti-TB drug treatment compared with Utilin's combined with anti-TB drugs treatment of pulmonary tuberculosis, the latter is good effect, and less adverse reaction.
应用推荐